First human trial of ETD-001 gel begins safety testing
Knowledge-focused
ENROLLING_BY_INVITATION
This early-stage trial tests the safety and tolerability of ETD-001 gel in healthy Chinese adults aged 18 to 60. Participants receive either the gel or a placebo, with doses increased gradually. The study aims to understand how the body processes the gel and whether it causes any…
Phase: PHASE1 • Sponsor: Etern Therapeutics Wuxi Limited • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC